Skip to main content

Table 3 Comet assay effects in COPD and controls stratified by genetic polymorphisms in base excision repair (BER), homologous recombination (HR) and nonhomologous DNA end joining (NHEJ) repair genes

From: Evaluation of DNA damage in COPD patients and its correlation with polymorphisms in repair genes

 

COPD

CONTROL

p*

BER

   

Subjects

n= 28

n=26

 

XRCC1- Arg399Gln

(ArgGln+GlnGln)

(ArgGln+GlnGln)

 

COMET ASSAY

   

 DI Alkaline

37.29±27.84

21.04±24.45

0.005

 DI Neutral

46.50±41.42

29.00±34.46

0.049

 DI Residual

150.89±87.99

51.88±44.20

0.000

Subjects

n= 13

n=15

 

OGG1- Ser326Cys

(SerCys+CysCys)

(SerCys+CysCys)

 

COMET ASSAY

   

 DI Alkaline

45.54±30.36

41.60±35.05

NS

 DI Neutral

60.54±31.63

55.27±47.68

NS

 DI Residual

142.38±92.56

56.00±34.98

0.001

HR and NHEJ

   

Subjects

n= 36

n=36

 

XRCC 3- Thr241Met

(ThrMet+MetMet)

(ThrMet+MetMet)

 

COMET ASSAY

   

 DI Alkaline

36.56±24.67

22.50±23.49

0.009

 DI Neutral

48.50±30.55

34.53±37.79

0.039

 DI Residual

134.75±77.16

54.06±42.88

0.000

Subjects

n= 11

n=07

 

XRCC 4- Ile401Thr

(IIeThr+ThrThr)

(IIeThr+ThrThr)

 

COMET ASSAY

   

 DI Alkaline

36.64±23.80

22.36±24.10

NS

 DI Neutral

47.36±28.15

36.43±37.30

NS

 DI Residual

134.50±80.74

49.02±36.07

0.013

  1. Data are presented as mean ± SD; DI, damage index; NS, nonsignificant;* Kruskal- Wallis Test.